Valproic acid in breast milk: how much is really there?

Area of Science:

• Pharmacology
• Toxicology
• Pediatrics

Background:

• Valproic acid (VPA) is a widely used anticonvulsant and mood-stabilizing medication.
• Concerns exist regarding the safety of VPA exposure in infants via breast milk.
• Understanding VPA transfer into breast milk is crucial for clinical decision-making.

Purpose of the Study:

• To quantify valproic acid concentrations in breast milk.
• To assess the relationship between total and unbound VPA in breast milk.
• To correlate VPA levels with clinical observations in breastfed infants.

Main Methods:

• Gas chromatographic/mass spectrometric assay used for VPA quantification.
• Analysis of 36 breast milk samples from 16 lactating patients treated with VPA.
• Comparison of total VPA concentrations with unbound VPA levels.

Main Results:

• VPA levels in breast milk ranged from 0.4-3.9 micrograms/ml (mean 1.9 +/- 1.2 microgram/ml).
• Total VPA concentration in breast milk was found to be only slightly higher than unbound VPA.
• Measured VPA levels are consistent with previous clinical observations.

Conclusions:

• Valproic acid transfers into breast milk at measurable concentrations.
• The unbound fraction of VPA in breast milk is significant.
• Findings support the clinical observation that infants exposed to VPA via breast milk tolerate it well.